Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Discover what are the best mutual funds for long term investing. Make informed choices to grow your wealth effectively over time.
27,580 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
As Rocket Lab broadens beyond launches into aerospace and defense, a renewed thesis supports a potential growth path ...
As Nvidia signals AI momentum and Marvell rides the wave, investors scan AI bookings and data-center demand to gauge ...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...
When a CEO sells thousands of shares, investors want to know what it signals. This guide explains how to read insider...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
Palantir’s stock dropped third from its peak as investor Michael Burry reveals a new critique centered on the company...
DoorDash sits near 52-week levels after a tough quarter that piled up costs from Deliveroo and grocery pushes. Yet Wa...
Credo Technology posted a strong Q3 with revenue growth and new TAM expansions, even as margins face near-term pressu...
A bold new AI model from Z.AI promises high performance without Nvidia chips. This article breaks down what GLM-5.2 m...
Investors are buzzing about SpaceX’s potential to reach a trillion-dollar value, a scenario sparked by Elon Musk’s co...
Howard Schultz moved from New York to Seattle 44 years ago with his wife and dog, launching a coffee obsession that t...